Soluplus® as a solubilizing excipient for poorly water-soluble drugs: Recent advances in formulation strategies and pharmaceutical product features

Faculty	Pharmacy	Year:	2023
Type of Publication:	ZU Hosted	Pages:
Authors:	Staff Zu Site Abstract In Staff Site
Journal:	Journal of Drug Delivery Science and Technology Elsevier	Volume:

Keywords :	Soluplus® , , solubilizing excipient , poorly water-soluble drugs:
Abstract:	Since the emergence of Soluplus® (SOL) as a commercial graft copolymer, several publications have been issued on its promising potential as a solubilizing excipient that could promote the dissolution rate and bioavailability of several poor

Author Related Publications

Mahmoud Mokhtar AhmedIbrahiem, "Phase Study and Characterization of Certain Developed Multicomponent Colloidal Systems and their Potential Application As Carriers for An Antimicrobial Agent", لايوجد, 1900 More
Amr Selim Ahmed Ali Abu Lila, "Ex-vivo/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome", J.Stage, 2013 More
Amr Selim Ahmed Ali Abu Lila, "Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?", Elsevier, 2012 More
Azza Ali Hassan Solyman, "Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system", Informa health, 2013 More
Amr Selim Ahmed Ali Abu Lila, "Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model", Elsevier, 2009 More